scispace - formally typeset
A

Anne Bergland

Researcher at Oslo University Hospital

Publications -  4
Citations -  76

Anne Bergland is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Randomized controlled trial & Disease. The author has an hindex of 2, co-authored 2 publications receiving 36 citations.

Papers
More filters
Journal ArticleDOI

A Stress Management App Intervention for Cancer Survivors: Design, Development, and Usability Testing.

TL;DR: This study illustrates how user-centered design and service design can be applied to identify and incorporate essential stakeholder aspects in the entire design and development process and facilitated development of a stress management intervention truly designed for the end users, in this case, cancer survivors.
Journal ArticleDOI

Pilot testing an app-based stress management intervention for cancer survivors.

TL;DR: App-based stress management interventions such as StressProffen can provide appreciated support for cancer survivors, should be easy to use, can provide significant stress reduction, and improve emotional well-being.
Journal ArticleDOI

A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia.

TL;DR: In this paper , the safety and effect of anthocyanins in maintaining cognitive functioning in people at increased risk for dementia was investigated. But, the results showed no significant group difference in episodic memory at the end of the study but statistically significant differences in slopes.
Journal ArticleDOI

What we know about the possible link between delirium and dementia with Lewy bodies, and why we need to learn more

TL;DR: Cullinan et al. as mentioned in this paper reviewed the published literature on diagnosis and management of delirium in LBD and report on three main concepts: (1) the lack of validated methods or tools to diagnose incident deliriam in L BD; (2) scant evidence on predictors of delirus onset in populations with diagnosed LBD, although poorer olfactory function and REM sleep behavioural disorder appear to predict deliriance in Parkinson's disease; and (3) further lack of clarity on which factors associated with delirius should increase the index of suspicion for prodromal DLB.